Clinical Trial Update: An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of an open-label Phase 1/2 study evaluating safety of single and multiple ascending doses of STK-001 in children and adolescen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• STK-001 (STK-001)

Snippet

Sponsor: Stoke Therapeutics, Inc | Conditions: Dravet Syndrome | Phase 1, Phase 2 | Status: COMPLETED